Access here alternative investment news about Chinese Biopharma Firm Waterstone Raises $61M Series C Round
Venture Capital

Chinese Biopharma Firm Waterstone Raises $61M Series C Round

by dealstreetasia.com posted 4weeks ago 41 views
SDIC JULI Investment Management led the fundraising. The post Chinese biopharma firm Waterstone raises $61m Series C round appeared first on DealStreetAsia.

In this article